Central Retinal Vein Occlusion Following Intravenous Immunoglobulin Treatment in a Patient with Pemphigus Vulgaris

J Ankara Univ Fac Med 2017;70(1):53-56

1. Sağlık Bilimleri University, Dışkapı Yıldırım Beyazıt Training and Research Hospital, Dermatology Clinic, Ankara, Turkey

2. Saglik Bilimleri University, Ulucanlar Eye Training and Research Hospital, Ophthalmology Clinic, Ankara, Turkey

3. Sağlık Bilimleri University, Dışkapı Yıldırım Beyazıt Training and Research Hospital, Ophthalmology Clinic, Ankara, Turkey

No information available.

No information available

Received Date: 10.01.2017

Accepted Date: 30.05.2016

PDF

Cite

Request

ABSTRACT

A 68-year-old male has been treated with prednisolone and intravenous immunoglobulin (IVIG) therapies with the diagnosis of pemphigus vulgaris. When he applied to receive the fifth session of IVIG therapy, he complained about visual loss. On the ophthalmologic examination, left central retinal vein occlusion (CRVO) was determined. There was no other detected underlying cause for CRVO and it was thought that central retinal vein thrombosis might be due to IVIG therapy.

IVIG treatment is generally accepted reliable for pemphigus vulgaris. However, it can rarely cause serious side effects like thrombosis. In literature, there are a few cases of central retinal vein occlusion due to IVIG therapy and none of these have dermatological disease as their etiology.

Keywords:

Central Retinal Vein Occlusion, Intravenous Immunoglobulin, Pemphigus Vulgaris